Waters' growth outlook is fueled by strong analytical sciences demand, BD synergies and innovation, even as China weakness and integration risks persist.
Waters NYSE: WAT President and Chief Executive Officer Udit Batra said the company's second-quarter performance exceeded expectations, supported by broad-based growth in its legacy analytical-science operations and early progress integrating acquired Becton Dickinson businesses.
Waters Corporation (WAT) Presents at U.S. All Stars Conference Transcript
WAT launches the BD FACSDiscover A7 globally, bringing advanced spectral flow cytometry, automation and standardized workflows to research labs.
Waters (WAT) reported earnings 30 days ago. What's next for the stock?
Waters NYSE: WAT reported second-quarter 2026 revenue of $1.645 billion, driven by 9% organic constant-currency growth and a 4% increase in revenue from its acquired Biosciences and Diagnostic Solutions businesses. The company raised its full-year outlook for organic revenue, acquired-business revenue and adjusted earnings per share after results exceeded its prior guidance.
WAT tops Q2 estimates, raises its 2026 outlook and posts broad-based growth across organic and acquired businesses.
Waters Corporation (WAT) Q2 2026 Earnings Call Transcript
Waters (WAT) came out with quarterly earnings of $3.05 per share, beating the Zacks Consensus Estimate of $3.01 per share. This compares to earnings of $2.95 per share a year ago.
Waters (WAT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Waters (WAT) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
The Swiss company agreed with Platinum Equity to create a joint venture and sell a 50% stake in its Waters and Beverages unit.